Dagnia Zeidlickis, Author at ��ϳԹ��Դ

Mark Claster elected ��ϳԹ��Դ Trustee

Dagnia Zeidlickis — Fri, 17 Jun 2022 11:30:45 +0000

On June 9, 2022, the ��ϳԹ��Դ (CSHL) Board of Trustees elected Mark L. Claster to the private, not-for-profit institution’s governing body. Claster is the Founder and Managing Partner of Carl Marks Advisors and the President of Carl Marks Securities. He is a trustee of Northwell Health and is the immediate past Chairman....

The post Mark Claster elected ��ϳԹ��Դ Trustee appeared first on ��ϳԹ��Դ.

Beautiful brain

Dagnia Zeidlickis — Wed, 15 Jun 2022 11:30:36 +0000

BARseq2 detects RNA from dozens of genes in thousands of neurons within one section of a mouse brain. Each color lights up a different set of genes." data-description="" />« Previous Story Next Story » CSHL Professor Anthony Zador has developed mapping technologies that identify connections of individual brain cells, pinpoint where a cell is located, and determine the specific function of that cell. Detailed wiring diagrams—connectomes—for the brain are critical for understanding brain development, function, and disease. These technologies, called MAPseq and BARseq,...

The post Beautiful brain appeared first on ��ϳԹ��Դ.

Tracy Johnson and Tom Lister join CSHL board

Dagnia Zeidlickis — Fri, 11 Mar 2022 12:30:47 +0000

On March 10, 2022, the ��ϳԹ��Դ (CSHL) Board of Trustees elected two new members to the private, not-for-profit institution’s governing body: Tracy L. Johnson, Ph.D., dean, Division of Life Sciences at UCLA; and Tom Lister, senior partner at the international private equity firm Permira. “CSHL will benefit from Tracy Johnson’s leadership in...

The post Tracy Johnson and Tom Lister join CSHL board appeared first on ��ϳԹ��Դ.

Famotidine clinical trial shows COVID-19 symptom reduction

Dagnia Zeidlickis — Thu, 10 Feb 2022 20:00:46 +0000

A high dose of famotidine, commonly known as Pepcid®, was found to have beneficial effects in adult patients with coronavirus disease 2019 (COVID-19), according to results of an outpatient clinical trial. Patients who took famotidine in this trial experienced a decrease of inflammation within the body and reported earlier alleviation of symptoms. Findings from the...

The post Famotidine clinical trial shows COVID-19 symptom reduction appeared first on ��ϳԹ��Դ.

CSHL and Veranome partner to accelerate brain mapping tech

Dagnia Zeidlickis — Tue, 18 Jan 2022 12:30:17 +0000

��ϳԹ��Դ (CSHL) and Veranome Biosystems LLC, an Applied Materials company, are collaborating to bring engineering solutions from the semiconductor manufacturing industry to neuroscience. Veranome is licensing CSHL brain mapping and spatial transcriptomics (cell-characterization) technologies that are based on in situ sequencing methods. CSHL Professor Anthony Zador has developed mapping technologies that identify...

The post CSHL and Veranome partner to accelerate brain mapping tech appeared first on ��ϳԹ��Դ.

Defining cells across diverse ancestries

Dagnia Zeidlickis — Wed, 17 Nov 2021 21:00:16 +0000

��ϳԹ��Դ (CSHL) Fellow Semir Beyaz is leading a multi-institutional team to generate a comprehensive atlas of uterine cells from patients of diverse ancestry. The $1 million project is part of the $28 million Chan Zuckerberg Initiative (CZI) Ancestry Network for the Human Cell Atlas, announced on October 29, 2021. A key objective...

The post Defining cells across diverse ancestries appeared first on ��ϳԹ��Դ.

Elizabeth Cogan Fascitelli elected a CSHL trustee

Dagnia Zeidlickis — Tue, 16 Nov 2021 20:00:41 +0000

��ϳԹ��Դ (CSHL) announces the election of businesswoman and philanthropist Elizabeth Cogan Fascitelli to the private, not-for-profit institution’s board of trustees. “Elizabeth Cogan Fascitelli brings a wealth of corporate, non-profit, and higher education sector experiences to our board,” said CSHL Chair Dr. Marilyn Simons. “Her enthusiasm is an inspiration and we are excited...

The post Elizabeth Cogan Fascitelli elected a CSHL trustee appeared first on ��ϳԹ��Դ.

New incubator model for CSHL spin-outs

Dagnia Zeidlickis — Mon, 07 Jun 2021 12:40:14 +0000

��ϳԹ��Դ (CSHL) is collaborating with Autobahn Labs, a new life sciences incubator, to catalyze the Laboratory’s early-stage discovery programs into spin-out companies that commercialize transformational new therapies. CSHL is a world leader in basic biological research and in target discovery for human genetic diseases like cancer. Autobahn will provide up to $5...

The post New incubator model for CSHL spin-outs appeared first on ��ϳԹ��Դ.

CSHL designs at-home clinical trial for COVID-19 treatment

Dagnia Zeidlickis — Fri, 29 Jan 2021 13:30:04 +0000

��ϳԹ��Դ (CSHL) and The Feinstein Institutes for Medical Research are recruiting patients in an entirely virtual, at-home, randomized, double-blind, placebo-controlled clinical trial. The study evaluates the safety and efficacy of the drug famotidine, or PEPCID, for the outpatient treatment of COVID-19 in adults. Tobias Janowitz, M.D., Ph.D., a medical oncologist, assistant professor...

The post CSHL designs at-home clinical trial for COVID-19 treatment appeared first on ��ϳԹ��Դ.

CSHL’s new organoid facility

Dagnia Zeidlickis — Thu, 05 Nov 2020 17:00:05 +0000

Organoid technology has advanced cancer research and is leading to the development of more effective treatments. Organoids are three-dimensional, live tissue models grown from patient tumors. The fact that organoids are alive makes them powerful as tools to understand a tumor’s response to a specific treatment. If a treatment is effective in the organoid model,...

The post CSHL’s new organoid facility appeared first on ��ϳԹ��Դ.

New genetic research to understand racial disparity in cancers

Dagnia Zeidlickis — Tue, 08 Sep 2020 21:00:34 +0000

Clinicians and scientists at ��ϳԹ��Դ (CSHL) will lead three new projects championed by the New York Genome Center (NYGC) to investigate the genetic contributions of ethnicity to the increased incidence of colon, endometrial, and pancreas cancers in African Americans. CSHL’s Cancer Center investigators will collaborate with Northwell Health Cancer Institute (Northwell) and...

The post New genetic research to understand racial disparity in cancers appeared first on ��ϳԹ��Դ.

Chan Zuckerberg Initiative awards $2 million to medRxiv

Dagnia Zeidlickis — Thu, 18 Jun 2020 16:00:32 +0000

CZI partners with ��ϳԹ��Դ, Yale University, and BMJ to help scientists share health and clinical research faster. Redwood City, CA — Today, the Chan Zuckerberg Initiative (CZI) announced $2 million in funding to support medRxiv, a free online repository dedicated to medical, clinical, and health sciences research in the form of preprints,...

The post Chan Zuckerberg Initiative awards $2 million to medRxiv appeared first on ��ϳԹ��Դ.

CSHL projects education outward

Dagnia Zeidlickis — Thu, 28 May 2020 12:00:24 +0000

The DNA Learning Center (DNALC) is the first and largest science center devoted entirely to public genetics education. Since 1988, DNALC educators have developed and delivered hands-on lab experiences to more than 670,000 students in the New York metropolitan area. As the COVID-19 pandemic closed schools everywhere, DNALC educators jumped into action to help sequestered...

The post CSHL projects education outward appeared first on ��ϳԹ��Դ.

CSHL is changing scientific exchange

Dagnia Zeidlickis — Wed, 27 May 2020 19:30:32 +0000

Last year, the Cold Spring Harbor Lab (CSHL) Meetings & Courses Program attracted 7,500 of the world’s scientists to twenty-six individual conferences, each spanning about 4 full days on the main CSHL campus in Long Island, NY. A highlight in the career path of most biologists and geneticists, the CSHL program brings as many as...

The post CSHL is changing scientific exchange appeared first on ��ϳԹ��Դ.

��ϳԹ��Դ announces exclusive license with plant breeding start-up Inari

Dagnia Zeidlickis — Tue, 16 Apr 2019 13:00:19 +0000

Cold Spring Harbor, NY — ��ϳԹ��Դ (CSHL) announced today an exclusive licensing agreement with partner Inari, a company that is advancing plant breeding by tapping nature’s genetic diversity. The technology developed by CSHL Professor and Howard Hughes Medical Institute Investigator Zachary Lippman allows Inari to tailor plant architecture and other traits in...

The post ��ϳԹ��Դ announces exclusive license with plant breeding start-up Inari appeared first on ��ϳԹ��Դ.

Marilyn Simons elected ��ϳԹ��Դ chair

Dagnia Zeidlickis — Fri, 07 Dec 2018 14:23:02 +0000

Cold Spring Harbor, NY — The governing body of the not-for-profit ��ϳԹ��Դ (CSHL) elected Dr. Marilyn Simons chair of the Board of Trustees on November 17, 2018. Long-time supporter of the world-renowned biological research and education institution, Simons is joined by Vice-Chairmen Charles Cogut, Robert Lindsay, and Paul Taubman. “I thank Marilyn...

The post Marilyn Simons elected ��ϳԹ��Դ chair appeared first on ��ϳԹ��Դ.

Ratner and Weisbrod join ��ϳԹ��Դ Board of Trustees

Dagnia Zeidlickis — Thu, 15 Mar 2018 13:22:41 +0000

Cold Spring Harbor, NY — ��ϳԹ��Դ (CSHL) today announced the addition of Bruce Ratner and Stuart Weisbrod to the private, non-profit institution’s board of trustees. Ratner is Chairman of the development company Forest City New York, notable for real estate projects including Brooklyn’s MetroTech Center and the new Cornell Tech campus on...

The post Ratner and Weisbrod join ��ϳԹ��Դ Board of Trustees appeared first on ��ϳԹ��Դ.

A transformative partnership

Dagnia Zeidlickis — Wed, 22 Nov 2017 20:46:58 +0000

“We’re at ��ϳԹ��Դ today, which is hallowed ground for scientific research. You can almost feel when you walk on the grounds that you’re in a special place and great things have happened here,” said New York State Governor Andrew Cuomo on October 12. “The potential we have on Long Island in this...

The post A transformative partnership appeared first on ��ϳԹ��Դ.

��ϳԹ��Դ to boost sharing of global scientific research in collaboration with the Chan Zuckerberg Initiative

Dagnia Zeidlickis — Wed, 26 Apr 2017 15:00:09 +0000

To accelerate the pace of scientific discovery, the bioRxiv preprint service will advance free distribution of research manuscript drafts Cold Spring Harbor, NY — ��ϳԹ��Դ (CSHL) today announced a new collaboration with the Chan Zuckerberg Initiative (CZI) that will help accelerate the understanding of life science for the benefit of human health...

The post ��ϳԹ��Դ to boost sharing of global scientific research in collaboration with the Chan Zuckerberg Initiative appeared first on ��ϳԹ��Դ.

Trinity College President Joins Board of ��ϳԹ��Դ

Dagnia Zeidlickis — Tue, 21 Mar 2017 09:00:59 +0000

Cold Spring Harbor, NY — ��ϳԹ��Դ (CSHL) today announced the election of Dr. Joanne Berger-Sweeney, president of Trinity College, to its Board of Trustees. “We are pleased to welcome Dr. Berger-Sweeney to the board of ��ϳԹ��Դ. Her leadership at premier academic institutions in the United States, as well as...

The post Trinity College President Joins Board of ��ϳԹ��Դ appeared first on ��ϳԹ��Դ.

Dagnia Zeidlickis, Author at ���ϳԹ���Դ

Mark Claster elected ���ϳԹ���Դ Trustee